Mixed cellular Hodgkin lymphoma, intra-abdominal nodes is a subtype of Hodgkin lymphoma characterized by the presence of mixed cellularity in lymphoid tissue. This condition primarily affects lymph nodes located in the abdominal cavity and is significant due to its potential for systemic symptoms and complications. Accurate coding with ICD-10 Code C81.23 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources.
What is ICD-10 Code C81.23 for Mixed cellular Hodgkin lymphoma, intra-abd nodes?
ICD-10 Code C81.23 specifically denotes Mixed cellular Hodgkin lymphoma affecting intra-abdominal lymph nodes. This condition is a variant of Hodgkin lymphoma, which can lead to significant morbidity if not diagnosed and treated promptly. The code should be utilized in clinical documentation and billing when a patient presents with this specific diagnosis, ensuring accurate representation of the patient's health status and facilitating appropriate treatment plans.
ICD-10 Code C81.23 – Clinical Definition and Explanation of Mixed cellular Hodgkin lymphoma, intra-abd nodes
Mixed cellular Hodgkin lymphoma, intra-abdominal nodes, is caused by the proliferation of abnormal lymphocytes in the lymphatic system, particularly affecting the abdominal lymph nodes. This condition can progress to systemic involvement, necessitating prompt medical intervention.
Key Clinical Features:
- Presence of abdominal lymphadenopathy, often detected through imaging studies.
- Systemic symptoms such as fever, night sweats, and weight loss.
- Potential for splenomegaly and hepatomegaly.
- Increased risk of secondary infections due to immunosuppression.
ICD-10 Code C81.23 for Mixed cellular Hodgkin lymphoma, intra-abd nodes – SOAP Notes & Clinical Use
ICD-10 Code C81.23 is utilized in SOAP notes to document the diagnosis of Mixed cellular Hodgkin lymphoma affecting intra-abdominal nodes. It plays a crucial role in capturing patient symptoms, assessments, and treatment plans, relevant in both acute and chronic care settings.
What Does ICD-10 Code C81.23 for Mixed cellular Hodgkin lymphoma, intra-abd nodes Mean in SOAP Notes?
In SOAP notes, ICD-10 Code C81.23 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Mixed cellular Hodgkin lymphoma. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Treatment Options for ICD-10 Code C81.23 – Mixed cellular Hodgkin lymphoma, intra-abd nodes
The management of Mixed cellular Hodgkin lymphoma, intra-abdominal nodes, often requires hospitalization for intensive treatment. Chemotherapy is the primary treatment modality, and supportive care is essential.
Antibiotic Therapy:
- Not applicable as this is not an infectious condition.
Supportive Care:
- Management of symptoms such as pain and nausea.
- Nutritional support to address weight loss.
- Psychosocial support for emotional well-being.
Infection Control:
- Standard precautions to prevent infections in immunocompromised patients.
- Monitoring for signs of infection during treatment.
How to Document Symptoms of Mixed cellular Hodgkin lymphoma, intra-abd nodes (ICD-10 C81.23) in SOAP Notes
Subjective:
- Patient reports abdominal pain and discomfort.
- History of unexplained weight loss over the past month.
- Complaints of night sweats and fatigue.
- No known allergies reported.
Objective:
- Abdominal examination reveals palpable lymphadenopathy.
- Vital signs: Temperature 101°F, heart rate 90 bpm.
- CBC shows anemia and elevated white blood cell count.
- Imaging studies confirm enlarged intra-abdominal lymph nodes.
Secure, compliant, and built for trust
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn more
SOAP Note Guidelines for Diagnosing Mixed cellular Hodgkin lymphoma, intra-abd nodes (ICD-10 Code C81.23)
Assessment:
- Diagnosis: Mixed cellular Hodgkin lymphoma, intra-abdominal nodes, moderate severity.
- ICD-10 Code: C81.23.
- Contributing factors: Possible genetic predisposition and environmental exposures.
- Triggers: None identified at this time.
Plan:
- Initiate chemotherapy regimen as per oncology guidelines.
- Schedule follow-up imaging to assess treatment response.
- Provide patient education on potential side effects of treatment.
- Arrange for nutritional counseling and psychosocial support.
Treatment & Plan Section for ICD-10 Code C81.23 – Mixed cellular Hodgkin lymphoma, intra-abd nodes
- First-line treatment includes combination chemotherapy regimens such as ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine).
- Non-pharmacologic strategies include dietary modifications and exercise as tolerated.
- Monitoring includes regular CBC and imaging studies to evaluate treatment efficacy.
- Follow-up practices involve scheduled oncology visits and symptom assessments.
Using ICD-10 Code C81.23 for Mixed cellular Hodgkin lymphoma, intra-abd nodes in Billing & SOAP Note Compliance
- Select accurate subcodes based on clinical severity or complications.
- Document symptoms clearly under Subjective (S) and Objective (O) in SOAP notes.
- Ensure treatment plans align with clinical guidelines to support justified billing.
- Only list CPT codes that are commonly billed with ICD-10 Code C81.23 based on standard medical coding practices.
Related ICD-10 Codes Often Used with Mixed cellular Hodgkin lymphoma, intra-abd nodes
- C81.20 – Hodgkin lymphoma, unspecified site
- C81.22 – Mixed cellular Hodgkin lymphoma, lymph nodes of head, face, and neck
- C81.21 – Mixed cellular Hodgkin lymphoma, lymph nodes of axilla and upper limb
- C81.24 – Mixed cellular Hodgkin lymphoma, lymph nodes of mediastinum
ICD-10 Code C81.23 in Medical Billing and Insurance for Mixed cellular Hodgkin lymphoma, intra-abd nodes
ICD-10 Code C81.23 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings.
Billing Notes:
- Ensure accurate documentation of the diagnosis and treatment plan to support claims.
- Use this code in inpatient and outpatient settings for consistency in billing.
- Include relevant clinical findings and treatment rationale in the medical record.
- Verify that all documentation aligns with payer requirements for reimbursement.
Common CPT Pairings:
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique, single or initial substance. |
| 85025 | Complete blood count (CBC) with automated differential white blood cell count. |
| 74176 | CT scan of the abdomen and pelvis with contrast. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
Frequently Asked Questions
Common Questions About Using ICD-10 Code C81.23 for Mixed cellular Hodgkin lymphoma, intra-abd nodes
What are the common symptoms of Mixed cellular Hodgkin lymphoma?
Common symptoms include abdominal pain, unexplained weight loss, night sweats, and fatigue. Patients may also experience fever and lymphadenopathy.
How is Mixed cellular Hodgkin lymphoma diagnosed?
Diagnosis typically involves imaging studies, biopsy of affected lymph nodes, and laboratory tests to assess blood counts and markers.
What treatments are available for this condition?
Treatment usually involves chemotherapy, and in some cases, radiation therapy may be indicated. Supportive care is also essential.
Is hospitalization required for patients with this diagnosis?
Yes, hospitalization may be necessary for chemotherapy administration and monitoring for potential complications.
